Company Active LTD

Company profile

Lombard Medical Limited

Lombard Medical |

Lombard Medical Limited is a UK company with status active founded in 1994 based in South East England.

CRN
02998639
Founded
1994
Age
31

Overview

Legal name
LOMBARD MEDICAL LIMITED
Region
South East England
Registered address
LOMBARD MEDICAL HOUSE
4 TRIDENT PARK
BASIL HILL ROAD DIDCOT
OXFORDSHIRE
OX11 7HJ
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

8 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

06 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

27 May
2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzUyMzA3NzMxM2FkaXF6a2N4 | Paper/PDF filed

Published 27 May 2026 23:15

23 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

12 Nov
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MjgwOTI0MmFkaXF6a2N4

Published 12 Nov 2024 12:54

07 Oct
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQzNzk3MjgyNWFkaXF6a2N4 | Paper/PDF filed

Published 08 Oct 2024 06:10

06 Dec
1994

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2018
Funded years
2018, 2023
Age at first award
23 years

Projects

2023 Collaborative R&D Lead participant

Meridian - Development and validation of an innovative fenestrated endovascular stent graft for aortic aneurysm repair

1 May 2023 to 31 Oct 2025

Awarded
£1,130,794
Total cost £1,615,420

Abdominal aortic aneurysm (AAA) causes ~6000 deaths/year in England and Wales, and \>175 000 deaths globally. These figures will likely increase due to our ageing population. AAAs occur in the aorta as it passes through the abdomen and may occur at any age but are most common as patients age, especially beyond 60 years of age. The condition is caused by w...

2018 Collaborative R&D Lead participant

Development of Key Technologies to Treat Aortic Aneurysms

1 Feb 2018 to 31 Jul 2021

Awarded
£480,664
Total cost £801,108

This project targets the treatment of abdominal aortic aneurysms; a fatal pathology most common in men in their mid sixties. It combines the clinical and medical implant skills of Lombard Medical with Microport's expertise in medical device manufacturing technology. This progam will develop a minimally invasive implant that can be used in day-case aneurys...

Product types

Collaborative R&D